Published Dec 10, 2024
Rare Disease, Big Impact with Matt Wilsey
Matt Wilsey narrates his inspiring journey from confronting his daughter's rare genetic disorder, NGLY1 deficiency, to founding Grace Science, a biotech company aiming for a cure. The episode explores the challenges and triumphs of navigating FDA regulations, strategic biotech partnerships, and the cutting-edge potential of gene therapy in combating rare diseases.

Topics covered
Popular Clips
Questions from this episode
- Asked by 6 people
- Asked by 5 people
- Asked by 1 person
- Asked by 1 person
Episode Highlights
Related Episodes


Solving Medical Mysteries in the World of Rare Disease
Answers 383 questions

The Power of a Platform Company with Josh Mandel-Brehm
Answers 383 questions

Drag & Drop Genome Editing
Answers 383 questions

A Fatal Inheritance with Lawrence Ingrassia
Answers 383 questions

CRISPR by Design with Benjamin Oakes
Answers 383 questions

Adapting Biopharma to AI with Greg Meyers
Answers 383 questions

Drugging the Undruggable with Greg Verdine
Answers 383 questions
The Science and Supply of GLP-1s with Brooke Boyarsky Pratt
Answers 383 questions

Fireside Chat with Sean Duffy
Answers 383 questions

Protecting the Golden Age of Medicine with John Crowley
Answers 383 questions

Network Medicine with Jonathan Swerdlin and Mark Hyman
Answers 383 questions

The Story of Schizophrenia
Answers 383 questions

The Power of Drug Discovery with Philip Tagari
Answers 383 questions

Adapting Biopharma to AI: A 2024 Update with Greg Meyers
Answers 383 questions

Journal Club: Why do only some people get severe COVID-19?
Answers 383 questions
